Antitumor Immune Mechanisms of the Anti-Complement Factor H Antibody GT103.

Bushey, Ryan T; Saxena, Ruchi; Campa, Michael J; Gottlin, Elizabeth B; He, You-Wen; Patz, Edward F

Bushey, Ryan T; Saxena, Ruchi; Campa, Michael J; Gottlin, Elizabeth B; He, You-Wen; Patz, Edward F.

Afiliação

Bushey RT; Department of Radiology, Duke University School of Medicine, Durham, North Carolina.
Saxena R; Department of Immunology, Duke University School of Medicine, Durham, North Carolina.
Campa MJ; Department of Radiology, Duke University School of Medicine, Durham, North Carolina.
Gottlin EB; Department of Radiology, Duke University School of Medicine, Durham, North Carolina.
He YW; Department of Immunology, Duke University School of Medicine, Durham, North Carolina.
Patz EF; Department of Radiology, Duke University School of Medicine, Durham, North Carolina.

Mol Cancer Ther ; 22(6): 778-789, 2023 06 01.

Article em En | MEDLINE | ID: mdl-36995981

Assuntos

Antineoplásicos; Neoplasias Pulmonares; Animais; Humanos; Fator H do Complemento/uso terapêutico; Anticorpos Monoclonais/farmacologia; Anticorpos Monoclonais/uso terapêutico; Neoplasias Pulmonares/patologia; Autoanticorpos/uso terapêutico; Antineoplásicos/uso terapêutico; Microambiente Tumoral

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pulmonares / Antineoplásicos Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google